Sequential treatment with abemaciclib+endocrine therapy inhibits cell proliferation and triggers apoptosis in cell lines resistant to CDK4/6i

First Author / 第一作者

Amber Pan

Institution / 單位

Eli Lilly and Company, Indianapolis, IN, USA

Audio / 音訊檔

Author Group / 作者群

Amber Pan (Non-author Presenter)1, Elisabet Zapatero-Solana1, Maria Ganado1, Maria Ortiz1, Cecilia Mur1, Lacey Litchfield1, Farhana Merzoug1, Oscar Puig*1, Maria Lallena1

Author Group Institution/ 作者群單位

1Eli Lilly and Company, Indianapolis, IN, USA (*Former Employee)

Category / 主題分類

Clinical Research

Keyword / 關鍵字

Apoptosis, CDK4/6i, Cell proliferation, Endocrine therapy

Back to list